Navigation Links
InspireMD Provides Corporate Update, Plans for 2012
Date:1/23/2012

als and Objectives

  • Complete the Master Trial and report results (2H, 2012) at a major interventional cardiology meeting.
  • Initiate and commence enrollment in the FDA Registration trial of MGuard™.
  • Obtain CE Mark approval for MGuard Carotid™ product. 
  • Initiate clinical study for MGuard Carotid™.
  • Expand commercial and manufacturing infrastructure in anticipation of MGuard™ demand, including the hiring of key senior executives.
  • Pursue additional registrations and distribution contracts in new countries.

MASTER Trial Enrollment on Track, Primary Endpoint Data Expected in Third Quarter

The MASTER (MGuard™ for Acute ST Elevation Reperfusion) randomized trial seeks to enroll 432 patients in a two-arm, parallel design study.  The objective is to evaluate the MGuard™ stent compared to commercially-approved BMS or DES products in achieving myocardial reperfusion in primary angioplasty for the treatment of STEMI patients. The primary endpoint is complete ST segment resolution.

Clinical follow-up will continue for one year and important secondary endpoints such as TIMI (Thrombolysis In Myocardial Infarction) flow, myocardial blush grade and MACE will be measured. Additional sub-studies for cardiac MRI and invasive angiography are planned as well. Dr. Gregg Stone, Director of Cardiovascular Research and Education, Columbia University in New York, is the study chairman.

Eli Bar, CTO and Vice President of Research and Development of InspireMD, commented: "We are pleased that enrollment in the MASTER Trial is advancing on schedule and we anticipate completing enrollment in the second quarter of 2012." He added: "The intent of the MASTER Trial is to provide additional supportive data based on a large, multi-national randomized trial."

The MASTER Trial is being conducted in 12 count
'/>"/>

SOURCE InspireMD
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients
2. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
3. InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
4. InspireMD Boosts MGuard Production Capacity
5. InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR"
6. InspireMD to Participate in Benchmark Company, LLC 2011 One-On-One Investor Conference
7. InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India
8. InspireMD Promotes MGuard™ at the EuroPCR 2011 Exhibition and Conference in Paris This Week
9. InspireMD Announces Year-to-Date 2011 Progress
10. InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation
11. Sol J. Barer, Ph.D. Joins InspireMD Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Calif. , June 19, 2013 ... management solutions, introduced the next-generation of its ... which allows health plans to provide their employer ... populations, health factors, medical and prescription drug claims, ... (Logo: http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) ...
(Date:6/19/2013)... NEW YORK , June 19, 2013 ... a brand new infographic summary of the results ... Nearly a third of all respondents stated that CROs would ... months. 50% of respondents will be running 6 or more ... association with the Clinical Trial Supply USA ...
(Date:6/19/2013)... , 19. Juni 2013 ... mit der Entwicklung von SCS microRESIST™, ... in der Beschichtung mit Parylene gelungen ... von biokompatiblem Parylene mit antimikrobiellen Eigenschaften ... schädlicher Mikroorganismen auf beschichteten medizinischen Geräten. ...
Breaking Medicine Technology:MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2Pharma IQ Presents the Latest Trends in Clinical Trial Supply 2Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2
... HealthCare Pharmaceuticals Inc. today announced that the U.S. Food ... for Natazia® (estradiol valerate and estradiol valerate/dienogest) tablets for ... not caused by any diagnosed conditions of the uterus ... for contraception.  With this approval, Natazia is the first ...
... HACKENSACK, N.J., March 14, 2012  Champions Oncology, Inc. (OTC: CSBR) ... Third Quarter Financial Results:Operating revenues were $2.4 million and $2.8 ... 2011, respectively, and $5.8 million and $5.3 million for the ... Total operating expenses were $4.2 million and $3.6 ...
Cached Medicine Technology:U.S. FDA Approves First and Only Oral Contraceptive Demonstrated to Treat Heavy Menstrual Bleeding (HMB) 2U.S. FDA Approves First and Only Oral Contraceptive Demonstrated to Treat Heavy Menstrual Bleeding (HMB) 3U.S. FDA Approves First and Only Oral Contraceptive Demonstrated to Treat Heavy Menstrual Bleeding (HMB) 4Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results 2Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results 3Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results 4Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results 5Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results 6Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results 7Champions Oncology Reports Fiscal 2012 Third Quarter Financial Results 8
(Date:6/19/2013)... (PRWEB) June 19, 2013 Blueforce ... and sensor machine software, today announced it has ... its Decentralized Fusion Engine technology. The award ... the acquisition of key strategic partnerships. , ... wireless collaboration and machine-to-machine (M2M) software products that ...
(Date:6/19/2013)... A blow to the head; a swift jarring to ... to hours. It’s understandable, but what else may follow ... traumatic brain injury. According to mayoclinic.com , usual ... But many other symptoms may follow, sometimes not for ... include ongoing headaches, dizziness, feeling like you’re in a fog, ...
(Date:6/19/2013)... 19, 2013 Walkingspree, a specialized wellness ... the launch of its new Facebook App. This is ... inspire participants to reach their program fitness goals. Consistent ... Walkingspree clients are given more tools to customize their ... , Corporate clients may choose whether or not they ...
(Date:6/19/2013)... Weight gain and obesity have been ... including heart disease, kidney failure and high blood pressure. ... and unnecessary fat, have many people searching for fast ... diets to not only allow patients to succeed ... aim to reduce the risk for many weight-related health ...
(Date:6/19/2013)... June 19, 2013 The reason for the ... because users can place a 4x8 flood tray inside the ... to work around. In addition, Gorilla Grow Tents are ... are the tallest, thickest and strongest grow tents on the ... grow tent standards. , Gorilla Grow Tents are ...
Breaking Medicine News(10 mins):Health News:Blueforce Awarded Patent for Decentralized Sensor Fusion 2Health News:Concussions Can Lead to Much More Than a Headache, According to MMTR Health Inc. Founder, Terry Moore, Neuromuscular and Cardiovascular Physiologist 2Health News:Walkingspree’s New Facebook Connectivity Boosts Accountability and Engagement 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 3Health News:Stealth Grow Tent Brand’s Popularity Rises 2
... disused proteins are eliminated by a cellular shredder called ... to dispose with Ubiquitin (Ub) in order to avoid ... in the ubiquitin-proteasome system can be fatal for the ... disorders but also developmental defects are the consequences. The ...
... the first scientific review of a dozen patients who have ... gene therapy technique is safe and may be effective at ... patients, half of whom live on Long Island, are in ... to medicines when they signed on for the experimental therapy. ...
... on June 26, after spending 23 days in the slammer. ... Angeles County Sheriff's Department's Inmate Reception Center. ,The exact ... ,Although her sentence was for 45 days, authorities have said ... good behaviour. ,"There was some confusion as to whether ...
... new details about how proteins used to destroy bacteria ... ,Gunnar K. Gouras, associate professor of neurology and ... York, and colleagues provide new insights into how these ... disease and raise hopes for a vaccine against the ...
... a credible scientific method for testing and measuring ... on XanGo Juice , indicate usage of the ... to high xanthone absorption. ,XanGo, LLC, ... leading scientific exploration of the whole mangosteen fruit ...
... is making all possible arrangements to look good on her yet ... thing that the socialite will do after being released on June ... complained to the press while in jail that she's not permitted ... going dry. ,So, the heiress has booked a facial ...
Cached Medicine News:Health News:Protein Targets for Carcinogenesis 2Health News:Gene Therapy for Parkinsons Disease 2Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 2Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 3Health News:New Technique to Measure Xanthone in Mangosteen 2Health News:New Technique to Measure Xanthone in Mangosteen 3
... Sun Design chairs offer support and freedom ... the chair are designed to take the ... comfort. The seat height and angle of ... single lever. The seat can be fixed ...
... A heavy duty chair with electrical ... 190 mm and seat rotation with ... rotation. A heavy duty chair with ... of 190 mm and seat rotation ...
Heine Beta 200 Streak Retinoscope 2.5v...
The 3.5v Retinoscope which provides superior illumination, is the right design for accurate refraction. It has the unique quality of one-hand operation and the comfort of a rubber brow rest....
Medicine Products: